Document is current
Any future updates will be listed below
-
Authors
Hikoso, Shungo https://orcid.org/0000-0003-2284-1970
Kida, Hirota
Sunaga, Akihiro
Nakatani, Daisaku
Okada, Katsuki
Dohi, Tomoharu
Sotomi, Yohei
Oeun, Bolrathanak
Sato, Taiki
Matsuoka, Yuki
Kitamura, Tetsuhisa
Yamada, Tomomi
Kurakami, Hiroyuki
Tamaki, Shunsuke
Seo, Masahiro
Yano, Masamichi
Hayashi, Takaharu
Nakagawa, Akito
Nakagawa, Yusuke
Yamada, Takahisa
Yasumura, Yoshio
Sakata, Yasushi
,
Seo, Masahiro
Watanabe, Tetsuya
Yamada, Takahisa
Hayashi, Takaharu
Higuchi, Yoshiharu
Masuda, Masaharu
Asai, Mitsutoshi
Mano, Toshiaki
Fuji, Hisakazu
Tamaki, Shunsuke
Masuda, Daisaku
Shutta, Ryu
Yamashita, Shizuya
Sairyo, Masami
Nakagawa, Yusuke
Abe, Haruhiko
Ueda, Yasunori
Matsumura, Yasushi
Nagai, Kunihiko
Yano, Masamichi
Nishino, Masami
Tanouchi, Jun
Arita, Yoh
Ogasawara, Nobuyuki
Ishizu, Takamaru
Ichikawa, Minoru
Takano, Yuzuru
Rin, Eisai
Shinoda, Yukinori
Tachibana, Koichi
Hoshida, Shiro
Izumi, Masahiro
Yamamoto, Hiroyoshi
Kato, Hiroyasu
Nakatani, Kazuhiro
Yasuga, Yuji
Nishio, Mayu
Hirooka, Keiji
Yoshimura, Takahiro
Kashiwase, Kazunori
Hasegawa, Shinji
Tani, Akihiro
Okumoto, Yasushi
Makino, Yasunaka
Onishi, Toshinari
Iwakura, Katsuomi
Kijima, Yoshiyuki
Kitao, Takashi
Fujita, Masashi
Harada, Koichiro
Kumada, Masahiro
Nakagawa, Osamu
Araki, Ryo
Yamada, Takayuki
Nakagawa, Akito
Yasumura, Yoshio
Matsuoka, Yuki
Sato, Taiki
Sunaga, Akihiro
Oeun, Bolrathanak
Kida, Hirota
Sotomi, Yohei
Dohi, Tomoharu
Akazawa, Yasuhiro
Nakamoto, Kei
Okada, Katsuki
Sera, Fusako
Kioka, Hidetaka
Ohtani, Tomohito
Takeda, Toshihiro
Nakatani, Daisaku
Hikoso, Shungo
Sakata, Yasushi
-
Funding
Funding for this research was provided by:
Roche Diagnostics K.K
FUJIFILM Toyama Chemical
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Received: 21 January 2023
Accepted: 1 September 2023
First Online: 29 November 2023
Declarations
:
: Shungo Hikoso reports relationships with Daiichi Sankyo Company, Bayer, Astellas Pharma, Pfizer Pharmaceuticals, Novartis Pharmaceuticals, Kowa Company, Otsuka Pharmaceutical, AstraZeneca, Eli Lilly Japan, and Boehringer Ingelheim Japan that include speaking and lecture fees. Shungo Hikoso reports relationships with Roche Diagnostics, FUJIFILM Toyama Chemical, and Bristol Myers Squibb that include funding grants. Daisaku Nakatani reports a relationship with Roche Diagnostics that includes speaking and lecture fees. Yohei Sotomi reports relationships with Abbott Vascular Japan, Boston Scientific Japan, TERUMO, Japan Lifeline, Biosensors, Medtronic, Daiichi-Sankyo, Bayer, Boehringer Ingelheim, and Bristol-Myers Squibb that include funding grants and speaking and lecture fees. Yohei Sotomi reports relationships with TERUMO, Asahi Intecc, NIPRO, and Shimadzu Corporation that include consulting or advisory fees. Yasushi Sakata reports relationships with Otsuka Pharmaceutical, Ono Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma Corporation and Actelion Pharmaceuticals that include speaking and lecture fees. Yasushi Sakata reports relationships with Roche Diagnostic, FUJIFILM Toyama Chemical, Abbott Medical Japan, Otsuka Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma Corporation and Biotronik that include funding grants. Yasushi Sakata reports that financial support was provided by the Japan Society for the Promotion of Science and the Japan Agency for Medical Research and Development. The other authors have no conflicts of interest to declare.
: The protocol of this study was reviewed and approved by the institutional review board (IRB) of Osaka University Hospital (approval ID: 15471) and the IRBs of each participating hospital in compliance with the principles of the Declaration of Helsinki of the World Medical Association. Informed consent was obtained from all individual participants included in the study.
